A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

ASMC-IPSMC-skin and Veneral Diseases, Sofia

Holdsworth House Medical Practice, Sydney

Alfred Hospital, Melbourne

"Medical Center Kordis", Pleven

Hospital Pulau Pinang-Pulau Pinang-21953, Georgetown Pulau Pinang

Non-Public Health Care Facility LABDERM, Ossy

Sunway Medical Centre, Selangor Darul Ehsan

Fachklinik Bad Bentheim, Bad Bentheim

Hospital Miguel Servet, Zaragoza

Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas

Hospital Kuala Lumpur, Kuala Lumpur

Hautmedizin Saar, Merzig

HOP Edouard Herriot, Lyon

Hospital Sultan Ismail, Johor Bahru

Dermatology Research Associates, Los Angeles

Clinical Trials Research Institute, Thousand Oaks

HOP Privé Antony, Antony

First OC Dermatology, Fountain Valley

Sarawak General Hospital, Kuching

Integrative Skin Science and Research-Sacramento-69402, Sacramento

National University Hospital-Singapore-42005, Singapore

STAT Research, CABA

Hospital Italiano de Buenos Aires, CABA

Hospital Alemán, Capital Federal

SimcoDerm Medical and Surgical Dermatology Centre, Barrie

Guelph Dermatology Research, Guelph

Dr. S. K. Siddha Medicine Professional Corporation, Newmarket

Kurume University Hospital, Fukuoka, Kurume

Ogaki Municipal Hospital, Gifu, Ogaki

The University of Tokyo Hospital, Tokyo, Bunkyo-ku

Nihon University Itabashi Hospital, Tokyo, Itabashi-ku

Tokyo Medical University Hospital, Tokyo, Shinjuku-ku

Vilnius University Hospital, Santariskiu, Vilnius

Provita Clinic, Warsaw

Royalderm, Warsaw

Seoul National University Hospital, Seoul